The DHSC has published a letter setting out the government’s plan and requests of industry and the wider supply chain ahead of the end of the Brexit transition period to help ensure the continuity of supply of medical goods into and out of the UK.
In his speech, the Chancellor Rishi Sunak outlined important short-term measures to support businesses hit by the coronavirus pandemic.
More than 20 leading biopharmaceutical companies announced the launch of the AMR Action Fund, a ground-breaking partnership that aims to bring 2-4 new antibiotics to patients by 2030.
The Independent Medicines and Medical Devices Safety Review, chaired by Baroness Julia Cumberlege, has published its report.
The Government should take immediate action to ‘supercharge’ private and public sector investment if it is to keep UK industries globally competitive, a new report by the Office for Health Economics warns.
The Government has published its R&D Roadmap with plans to cement the UK as the world’s leading research and science superpower.
The data published on Disclosure UK today shows that the industry invested £381.2 million on R&D activities in the UK during 2019, up from £377.3million in 2018.
The ABPI is launching a public consultation on the proposed 2021 ABPI Code of Practice for the pharmaceutical industry from today. The aim is to create a new look, more user-friendly ABPI Code of Practice.
The Department of Health has announced that a scheme to kickstart the development of new antibiotics by offering to pay pharmaceutical companies upfront for their work will start this week.
Before the coronavirus pandemic, this Thursday would have been the annual Chwarae Teg Womenspire Awards 2020 - celebrating the achievements of women from all backgrounds and stages in life or work across Wales.